Creative Planning’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$587K Buy
18,237
+2,221
+14% +$82.2K ﹤0.01% 2892
2025
Q4
$674K Buy
16,016
+7,562
+89% +$305K ﹤0.01% 2592
2025
Q3
$290K Buy
+8,454
New +$243K ﹤0.01% 3176
2025
Q2
Sell
-16,159
Closed -$479K 3798
2025
Q1
$479K Sell
16,159
-254
-2% -$9.68K ﹤0.01% 2326
2024
Q4
$650K Buy
16,413
+4,771
+41% +$181K ﹤0.01% 1985
2024
Q3
$396K Buy
+11,642
New +$328K ﹤0.01% 2301
2017
Q3
Sell
-1,262
Closed -$11K 3648
2017
Q2
$11K Buy
+1,262
New +$10.3K ﹤0.01% 3583

Other funds holding VCYT

Creative Planning's VCYT Position: Q1 2026 in Review

Creative Planning increased its Veracyte (VCYT) stake by 14% in Q1 2026, buying an estimated $82.2K and bringing the position to 18,237 shares worth $587K. The position accounts for ﹤0.01% of the portfolio, ranked #2892.

Creative Planning first reported a position in VCYT in Q2 2017 and has held it in 7 quarters since. The position peaked at $674K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Creative Planning held 18,237 shares of Veracyte worth $587K as of Q1 2026.
  • Creative Planning bought 2,221 Veracyte shares in Q1 2026, an estimated $82.2K.
  • Veracyte made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #2892 holding.
  • Creative Planning first reported a position in Veracyte in Q2 2017 and has held it in 7 quarters since.
  • Creative Planning's Veracyte position peaked at $674K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.